All articles published by MDPI are made immediately available worldwide under an open access license. No special
permission is required to reuse all or part of the article published by MDPI, including figures and tables. For
articles published under an open access Creative Common CC BY license, any part of the article may be reused without
permission provided that the original article is clearly cited. For more information, please refer to
https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature
Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for
future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive
positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world.
Editors select a small number of articles recently published in the journal that they believe will be particularly
interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the
most exciting work published in the various research areas of the journal.
The year 2024 marks the 30th anniversary of Current Oncology, a peer-reviewed open access journal on clinical oncology. With an Impact Factor of 2.6 and a CiteScore of 3.3, the journal is covered in Scopus, SCIE (Web of Science), PubMed, MEDLINE, PMC, Embase, and other databases. The journal has published more than 3,800 papers from more than 17,200 authors, who are from 98 countries. More than 5,300 reviewers have reviewed the journal at least once. We value all contributions made by our editors, authors, and reviewers equally.
In honor of the journal’s 30th anniversary, we are reflecting on our past accomplishments and embarking on an exciting new chapter. We invite you to join us in celebrating this milestone for our journal and to explore the content we have prepared for you below.
The Canadian Association for Psychosocial Oncology (CAPO) would like to recognize the outstanding achievements of the Current Oncology journal, as it celebrates its 30th year. We are so pleased and proud
The Canadian Association for Psychosocial Oncology (CAPO) would like to recognize the outstanding achievements of the Current Oncology journal, as it celebrates its 30th year. We are so pleased and proud to be a partner with a publication which exemplifies scholarly excellence. Our members benefit greatly from this partnership and we all enjoy working with the great team at CO and seeing them at our Annual Conference! Congratulations from CAPO!
The year 2024 marks the 30th anniversary of the journal, Current Oncology, an international, scientific, peer-reviewed, open access journal published bi-monthly. The Canadian Association of Medical Oncologists and its
The year 2024 marks the 30th anniversary of the journal, Current Oncology, an international, scientific, peer-reviewed, open access journal published bi-monthly. The Canadian Association of Medical Oncologists and its members value its ongoing relationship with Current Oncology and we applaud them on their ongoing success. Congratulations and we look forward to collaborating for many more years!
Section Editor-in-Chief (Section Medical Oncology)
La Maddalena Cancer Center, Italy
As a member of the editorial board, it is a pleasure to be able to celebrate the thirtieth anniversary of Current Oncology. The journal is now a scientific reference
As a member of the editorial board, it is a pleasure to be able to celebrate the thirtieth anniversary of Current Oncology. The journal is now a scientific reference point for oncologists around the world. It's an honour for me to be part of this team.
Section Editor-in-Chief (Section Gastrointestinal Oncology)
University of British Columbia, Canada
I am delighted to congratulate Current Oncology on the journal’s 30 Year Anniversary!Born in Canada, Current Oncology has played an important role in disseminating evidence that has informed
I am delighted to congratulate Current Oncology on the journal’s 30 Year Anniversary!Born in Canada, Current Oncology has played an important role in disseminating evidence that has informed and improved the practice of clinical oncology.I am especially grateful for the honour of having served as Editor-in-Chief for Current Oncology and proud of its continued growth and expanding impact across the world.
Section Editor-in-Chief (Section Thoracic Oncology)
Centre Hospitalier de L'Universite de Montreal, Canada
I am happy to be part of the Current Oncology family as a Section Editor for lung cancer as a scientific contributor over many years. I wish the journal will
I am happy to be part of the Current Oncology family as a Section Editor for lung cancer as a scientific contributor over many years. I wish the journal will enjoy continued success over the next 30 years!
Section Editor-in-Chief (Section Oncology Nursing)
University of Toronto, Toronto, Canada
Congratulations on the 30th Anniversary. It is a remarkable achievement to reach this milestone and to have contributed leadership to the specialty of oncology. Current Oncology has served as a
Congratulations on the 30th Anniversary. It is a remarkable achievement to reach this milestone and to have contributed leadership to the specialty of oncology. Current Oncology has served as a unique publication in the field, embracing all disciplines and relevant research methods. Its growth and "staying power" is a testament to the relevance and contribution to oncology. The efforts to maintain high quality in this publication are commendable and a reason to be proud of the product!!
Author
University of Miami Miller School of Medicine, FL, USA
Publishing our work, "Soft Tissue Masses of the Hand: A Review of Clinical Presentation and Imaging Features" in Current Oncology allows us to reach a wide international audience. The peer
Publishing our work, "Soft Tissue Masses of the Hand: A Review of Clinical Presentation and Imaging Features" in Current Oncology allows us to reach a wide international audience. The peer review process was conducted in a timely manner, with responsive editorial support throughout the publication process. I look forward to working with the journal on future submissions.
As part of this collaboration, all members of the societies above will enjoy a discount on the Article Processing Charge (APC) when submitting articles to Current Oncology. The collaboration goes beyond the discount benefit offered to members and includes other services as well as cross-promotions.
2. Welcoming the New Section Editors-in-Chief of Current Oncology
We are pleased to announce that Prof. Dr. Matthias May, Prof. Dr. Katrin Scheinemann, and Dr. Stuart Peacock have been appointed Editors-in-Chief of the Sections “Genitourinary Oncology”, “Childhood, Adolescent and Young Adult Oncology”, and “Health Economics”, respectively. We look forward to their contributions to Current Oncology (ISSN: 1718-7729).
Name: Prof. Dr. Matthias May
Affiliation: Department of Urology, St. Elisabeth Hospital Straubing, 94315 Straubing, Germany Interests: bladder cancer; prostate cancer; renal cell carcinoma; robot-assisted surgery; biomarker-based oncology studies; prognostic outcome models; translational research, multicenter projects in genitourinary oncology research
Name: Prof. Dr. Katrin Scheinemann Affiliation: Division of Hematology/Oncology, Children’s Hospital of Eastern Switzerland, 9006 St. Gallen, Switzerland Interests: survivorship; long-term follow-up care; neurooncology; AYA oncology
Name: Prof. Dr. Stuart Peacock
Affiliation: 1. Leslie Diamond Chair in Cancer Survivorship, Faculty of Health Sciences, Simon Fraser University, Burnaby, BC V5A 1S6, Canada 2. Cancer Control Research, BC Cancer, Vancouver, BC V5Z 1L3, Canada 3. Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, BC V5Z 1L3, Canada Interests: cancer survivorship; health economics; quality of life; priority setting; public engagement
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.
